Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

687 studies match

clinicaltrialsPublishedShowing 501–550 of 687 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00545688	A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.	completed	Phase 2	417	Hoffmann-La RocheINDUSTRY	18	Aug 15, 2017	clinicaltrials
NCT00633295	Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor	completed	Phase 2	9	Novartis PharmaceuticalsINDUSTRY	1	Jun 22, 2017